Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 51
  • Journal CiteScore: 46.50
  • Journal Impact Factor: 26.99
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Personalized & precision medicine (PPM) as a model of healthcare of the newest generation: The motivation for biopharma and translational resources to move ahead together

17th Edition of International Conference and Exhibition on Pharmaceutics and Novel Drug Delivery Systems
October 04-06, 2018 Moscow, Russia

Sergey Suchkov, A I Evdokimov, Jeff Skolnick, Maria Studneva, Marc Hendrikx, Arsnii Sadykov and Paul Barach

Sechenov University, Russia Moscow Engineering Physical Institute (MEPhI), Russia A I Evdokimov Moscow State Medical & Dental University, Russia ISPM, Japan PMC, USA EPMA, Belgium AHA, USA Jessa Ziekenhuis, Belgium Childrens Hospital of Michigan, DMC Detroit Medical Center, Wayne State University School of Medicine, USA Georgia Institute of Technology, USA

Keynote: Int J Drug Dev & Res

Abstract:

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized medicine (PM). To achieve the implementa-tion of PM concept into the daily practice including clinical cardiology, it is necessary to create a fundamentally new strategy based upon the subclinical recognition of bioindicators (biopredictors and biomarkers) of hidden abnormalities long before the disease clinically manifests itself. Each decision-maker values the impact of their decision to use PM on their own budget and well-being, which may not necessarily be optimal for society as a whole. It would be extremely useful to integrate data harvesting from different databanks for applications such as prediction and personalization of further treatment to thus provide more tailored measures for the patients and persons-at-risk resulting in improved outcomes whilst securing the healthy state and wellness, reduced adverse events, and more cost effective use of health care resources. One of the most advanced areas in cardiology is atherosclerosis, cardiovascular and coronary disorders as well as in myocarditis. A lack of medical guidelines has been identified by the majority of responders as the predominant barrier for adoption, indicating a need for the development of best practices and guidelines to support the implementation of PM into the daily practice of cardiologists! Implementation of PM requires a lot before the current model “physician-patient” could be gradually displaced by a new model “medical advisor-healthy person-at-risk”. This is the reason for developing global sci-entific, clinical, social, and educational projects in the area of PM to elicit the content of the new branch. Recent Publications 1. T A Bodrova, D S Kostyushev, E N An-tonova, Sh. Slavin, D A Gnatenko, M O Bo-charova, M Legg, P Pozzilli and S V Suchkov (2012) Introduction into PPPM as a new paradigm of public health service: an integrative view. EPMA Journal 3(16):3-16. 2. Sergey Suchkov. Predictive, Preventive and Personalized Medicine (PPPM) as an inte-grative part of national healthcare services to move ahead In: Proceedings (Programme Book) of the ESBB Annual Meeting, Vero-na, Italy, October 8th-11th, 2013, P. 30- 31, S-13 3. I A Sadkovsky, O Golubnitschaja, M A Mandrik, M A Studne-va, H Abe, H Schroeder, E N Antono-va, F Betsou, T A Bodrova, K Payne and S V Suchkov (2014) PPPM (predictive, preventive and personalized medicine) as a new model of the na-tional and international healthcare services and thus a promising strategy to prevent a disease: from basics to practice. International Journal of Clinical Medicine 5:855-870. 4. Zemskov V M, Alekseev A A, Gnatenko D A, Kozlova M N, Shishkina N S, Zemskov A M, Zhegalova I V, Bleykhman D A, Bahov N I and Suchkov S V (2016) Overex-pression of nitric oxide synthase re-stores circulating angiogenic cell function in pa-tients with coronary artery disease: implica-tions for autologous cell therapy for myo-cardial infarction. The Journal of the Ameri-can Heart Association 5:1-18. 5. Zemskov A, Zemskov V, Zemskova V, Buch T, Chernova L Bleykhman D, Mar-shall T, Abe H, Zhegalova I, Barach P and Suchkov S (2017) A stepwise screening pro-tocol to secure the module-based treatment for managing immunopathology. Interna-tional Journal of Information Research and Review 4(1):3507-3510.

Biography :

Sergey Suchkov graduated from Astrakhan State Medical University and was awarded with MD and maintained his PhD and Doctor’s degree. He was working for Helmholtz Eye Research Institute and Moscow Regional Clinical Research Institute. He was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. Currently, he is a Director of Center for Personalized Medicine, Sechenov University; Chair of the Department for Translational Medicine, Moscow Engineering Physics University and Secretary General of United Cultural Convention, Cambridge, UK. He is a Member of the New York Academy of Sciences; American Chemical Society; American Heart Association; AMEE, Dundee, UK; EPMA, Brussels, EU; PMC, Washington, DC, USA and ISPM, Tokyo, Japan.

E-mail: ssuchkov57@gmail.com